Lupkynis Unia Europejska - polski - EMA (European Medicines Agency)

lupkynis

otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - leki immunosupresyjne - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).

Amvuttra Unia Europejska - polski - EMA (European Medicines Agency)

amvuttra

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - inne leki na układ nerwowy - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Lytgobi Unia Europejska - polski - EMA (European Medicines Agency)

lytgobi

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - środki agenci - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Arexvy Unia Europejska - polski - EMA (European Medicines Agency)

arexvy

glaxosmithkline biologicals s.a.  - respiratory syncytial virus recombinant glycoprotein f stabilised in the pre-fusion conformation (rsvpref3) produced in chinese hamster ovary (cho) cells by recombinant dna technology - infekcje wirusem oddechowym - szczepionki - arexvy is indicated for active immunisation for the prevention of lower respiratory tract disease (lrtd) caused by respiratory syncytial virus in adults 60 years of age and older. stosowanie tej szczepionki powinno odbywać się zgodnie z oficjalnymi zaleceniami.

Inaqovi Unia Europejska - polski - EMA (European Medicines Agency)

inaqovi

otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - białaczka, szpikowe - Środki przeciwnowotworowe - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.

Theraflu Complete 500 mg + 65 mg Tabletki powlekane Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

theraflu complete 500 mg + 65 mg tabletki powlekane

haleon poland sp. z o.o. - paracetamolum + coffeinum - tabletki powlekane - 500 mg + 65 mg

Theraflu ExtraGRIP 650 mg + 10 mg + 20 mg Proszek do sporządzania roztworu doustnego Polska - polski - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

theraflu extragrip 650 mg + 10 mg + 20 mg proszek do sporządzania roztworu doustnego

delfarma sp. z o.o. - proszek do sporządzania roztworu doustnego - 650 mg + 10 mg + 20 mg

Lumeblue (previously known as Methylthioninium chloride Cosmo) Unia Europejska - polski - EMA (European Medicines Agency)

lumeblue (previously known as methylthioninium chloride cosmo)

alfasigma s.p.a. - chlorek metylotioniny - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

Adakveo Unia Europejska - polski - EMA (European Medicines Agency)

adakveo

novartis europharm limited - crizanlizumab - anemia, sickle cell - other hematological agents - adakveo is indicated for the prevention of recurrent vaso occlusive crises (vocs) in sickle cell disease patients aged 16 years and older. it can be given as an add on therapy to hydroxyurea/hydroxycarbamide (hu/hc) or as monotherapy in patients for whom hu/hc is inappropriate or inadequate.

Tessie Unia Europejska - polski - EMA (European Medicines Agency)

tessie

orion corporation - tasipimidine sulfate - other hypnotics and sedatives - psy - alleviation of situational anxiety and fear in dogs triggered by e. travel, noise, owner departure, veterinary visits.